Last reviewed · How we verify
CKD-348
At a glance
| Generic name | CKD-348 |
|---|---|
| Sponsor | Chong Kun Dang Pharmaceutical |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(6) (PHASE1)
- A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348 (PHASE1)
- A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(2) (PHASE1)
- A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(5) (PHASE1)
- A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(3) (PHASE1)
- Clinical Trial to Evaluate the Tolerability and the Pharmacokinetics of CKD-348 (PHASE1)
- A Clinical Trial to Evaluate the Pharmacokinetics and Tolerability of CKD-348 (PHASE1)
- Clinical Study to Evauate the Pharmacokinetic Profiles and Safety of CKD-348 in Healthy Volunteers (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |